| Name: | Acarbose EP Impurity C |
| Catalogue No. | VL5070004 |
| CAS No. | N/A |
| Molecular Formula | C25H43NO18 |
| Molecular Weight | 645.6 |
| Status | Under Development |
| IUPAC Name | 2-((6-((4,5-dihydroxy-6-methyl-6-((4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl)amino)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
| Description | Acarbose EP Impurity C is an impurity produced during the synthesis of Acarbose that is a complex oligosaccharide that belongs to the class of medications recognized as a-glucosidase inhibitors. It may also repress pancreatic a-amylase that catalyzes the first step present in the digestion of starch. |
| References | Wang, Ya-Jun, et al. “Analysis and Determination of Anti-Diabetes Drug Acarbose and Its Structural Analogs.” Current Pharmaceutical Analysis, vol. 7, no. 1, Feb. 2011, pp. 12–20, https://doi.org/10.2174/157341211794708721. Martin, Anne E., and Patricia A. Montgomery. “Acarbose: An a-Glucosidase Inhibitor.” American Journal of Health-System Pharmacy, vol. 53, no. 19, Oct. 1996, pp. 2277–90, https://doi.org/10.1093/ajhp/53.19.2277. |
